EPI Program Achievements

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
D04AB01	VERSATIS	B	Lidocaine - 5%	5%	Patch	2,772,347 L.L
D02AC	VASELINE PURE	G	Vaseline pure - 20g	20g	Ointment	103,668 L.L
D02AC	VASIDEX	G	Vaseline pure - 15g	15g	Ointment	78,071 L.L
D05AA	VASELINE ICHTYOLEE	G	Ichthyamol - 10%	10%	Ointment	103,668 L.L
J07AL02	VAXNEUVANCE	B	Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F, 9V,14, 18C, 19A, 19F, 22F, 23F,33F (2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg) Conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate adjuvant -		Injectable suspension	6,988,413 L.L
J07BB01	VAXIGRIPTETRA, VACCIN GRIPPAL QUADRIVALENT (INACTIVE A VIRION FRAGMENTE)	B	Influenza vaccine virus (inactivated, split) - 15mcg/4strains/0.5ml		Injectable suspension	970,254 L.L
J07BC02	VAQTA	B	Hepatitis A, inactivated, whole virus - 25U/0.5ml	25U/0.5ml	Injectable suspension	2,539,862 L.L
J07BK01	VARICELLA VACCINE LIVE	BioTech	Varicella-herpes zoster virus (Oka strain), grown in human diploid cells (SV-cell line), live attenuated -		Injectable suspension	3,104,276 L.L
N03AX18	VIMPAT	B	Lacosamide - 10mg/ml	10mg/ml	Injectable solution	13,225,715 L.L
J01MA12	VLOFINOX	G	Levofloxacin (hemihydrate) - 500mg/100ml	500mg/100ml	Injectable solution	814,369 L.L
A11GA01	VITAMIN C S.A.L.F.	G	Ascorbic acid (vit C) - 500mg/5ml	500mg/5ml	Injectable solution	498,566 L.L
B05AA01	VIALEBEX	BioHuman	Albumin human - 200g/L	200g/L	Injectable solution	3,417,391 L.L
B05AA07	VOLUVEN	B	Starch poly(O-2-Hydroxyethyl) - 6%	6%	Injectable solution	987,724 L.L
A03FA01	VOMICARE INJECTION BP IM/IV	G	Metoclopramide - 10mg/2ml	10mg/2ml	Injectable solution	247,267 L.L
S01LA09	VABYSMO	B	Faricimab - 6mg/0.05ml	6mg/0.05ml	Injectable solution	54,991,170 L.L
M01AB05	VOLDEN	G	Diclofenac sodium - 75mg/3ml	75mg/3ml	Injectable solution	422,351 L.L
M01AB05	VOTREX	G	Diclofenac sodium - 75mg/3ml	75mg/3ml	Injectable solution	345,368 L.L
A04AA05	VONAXI	G	Palonosetron HCl - 250mcg/5ml	250mcg/5ml	Injectable solution	1,490,321 L.L
J07BK01	VARIVAX	B	Varicella virus, live attenuated - 1350PFU		Injectable powder for suspension+diluent	4,102,751 L.L
L01BC07	VAPREZA 100	G	Azacitidine - 100mg	100mg	Injectable powder for suspension	10,706,993 L.L
J01XA01	VANCO MEDIS 500MG	G	Vancomycin - 500mg	500mg	Injectable powder for solution	998,475 L.L
J01XA01	VANCOMYCIN HIKMA	G	Vancomycin (HCl) - 500mg	500mg	Injectable powder for solution	998,475 L.L
J01XA01	VANCOTEN	G	Vancomycin (HCl) - 500mg	500mg	Injectable powder for solution	537,537 L.L
J01XA01	VOXIN	G	Vancomycin (HCl) - 500mg	500mg	Injectable powder for solution	546,944 L.L
J02AC03	V-FEND	B	Voriconazole - 200mg	200mg	Injectable powder for solution	8,078,564 L.L
J02AC03	VORICONAZOLE STRAGEN	G	Voriconazole - 200mg	200mg	Injectable powder for solution	5,841,683 L.L
L01XG01	VELZOME	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	17,462,517 L.L
J01CR02	VAAMOX IV	G	Amoxicillin - 1g, Clavulanic Acid - 200mg		Injectable powder	225,766 L.L
J01CR02	VAAMOX IV	G	Amoxicillin - 1g, Clavulanic Acid - 200mg		Injectable powder	2,150,148 L.L
J07BK01	VARILRIX + SOLVENT IN SYRINGE	B	Varicella virus, live attenuated - ?1033 PFU	?1033 PFU	Injectable lyophilised powder for solution+diluent	3,473,833 L.L

إنجازات البرنامج